Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation

• Published in: International journal of molecular sciences 2020-05, Vol.21 (10), p.3663
• Main Authors: Park, Ki Hyun, Ryu, Ji Hyeong, Bae, Hyunjoo, Yun, Sojeong, Jang, Joo Hee, Han, Kyungja, Cho, Byung Sik, Kim, Hee-Je, Lee, Hyeyoung, Oh, Eun-Jee
• Format: Article
• Language: English
• Subjects: Activation; Acute myeloid leukemia; Adolescent; Adult; Aged; Cell Line, Tumor; Cytokines; Cytomegalovirus; Cytomegalovirus - immunology; Cytomegalovirus Infections - complications; Cytomegalovirus Infections - immunology; Cytotoxicity; Disease; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic stem cells; Humans; Immunophenotyping; Infections; Interferon; Interferon-gamma - metabolism; Killer Cells, Natural - immunology; Leukemia; Leukemia, Myeloid, Acute - immunology; Leukemia, Myeloid, Acute - therapy; Leukemia, Myeloid, Acute - virology; Lymphocytes; Male; Middle Aged; Myeloid leukemia; Natural killer cells; Patients; Phenotypes; Receptors, Natural Killer Cell - metabolism; Risk Factors; Stem cell transplantation; Stem cells; Transplantation; Transplantation, Homologous; Viremia; γ-Interferon
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21103663

Cytomegalovirus (CMV) infection has a significant impact in patients after allogeneic hematopoietic stem cell transplantation (HSCT). We investigated natural killer (NK) cell reconstitution and cytotoxic/cytokine production in controlling CMV infection, especially severe CMV disease in HSCT patients. Fifty-eight patients with acute myeloid leukemia (AML) who received allo-HSCT were included. We monitored NK reconstitution and NK function at baseline, 30, 60, 90, 120, 150, and 180 days after HSCT, and compared the results in recipients stratified on post-HSCT CMV reactivation ( 23), non-reactivation ( 24) versus CMV disease ( 11) groups. The CMV disease group had a significantly delayed recovery of CD56dim NK cells and expansion of FcRγ-CD3ζ+NK cells started post-HSCT 150 days. Sequential results of NK cytotoxicity, NK cell-mediated antibody-dependent cellular cytotoxicity (NK-ADCC), and NK-Interferon-gamma (NK-IFNγ) production for 180 days demonstrated delayed recovery and decreased levels in the CMV disease group compared with the other groups. The results within 1 month after CMV viremia also showed a significant decrease in NK function in the CMV disease group compared to the CMV reactivation group. It suggests that NK cells' maturation and cytotoxic/IFNγ production contributes to CMV protection, thereby revealing the NK phenotype and functional NK monitoring as a biomarker for CMV risk prediction, especially CMV disease.